Author Question: Jenny is an officer of a corporation. She made a difficult business decision. When challenged about ... (Read 128 times)

maegan_martin

  • Hero Member
  • *****
  • Posts: 532
Jenny is an officer of a corporation. She made a difficult business decision. When challenged about her decision, the court ruled she had acted in good faith and that the business judgment rule applied. As such
 A)Jenny will not be held personally liable for any harm her decision has caused the company.
 B)Jenny's decision will be reviewed by a court.
 C)Jenny is immune from a lawsuit.
 D)Jenny must resign from the board.

Question 2

The Japanese technical barriers are imposed to protect its citizens and based on performance standards.
  Indicate whether the statement is true or false



momo1250

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

A

Answer to Question 2

FALSE



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library